Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JBPOS0101 for Refractory Infantile Spasms
NCT03976076Phase 2Terminated
- Sponsor
- Bio-Pharm Solutions
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of JBPOS0101 in infantile epileptic spasms syndrome (IESS), sponsored by Bio-Pharm Solutions. Started Apr 2020; status: terminated.
02
Drugs
JBPOS0101
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT03976076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03976076.